Anti-cytokine therapeutics and infections

This publication has 44 references indexed in Scilit:

• Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing Agent
  New England Journal of Medicine, 2001
• Optimizing therapeutic strategies to inhibit circulating soluble target molecules with monoclonal antibodies: example of the soluble IL-6 receptors
  European Journal of Immunology, 2000
• Interleukin-1 Receptor Type I Gene-Deficient Mice Are Less Susceptible toStaphylococcus epidermidisBiomaterial-Associated Infection than Are Wild-Type Mice
  Infection and Immunity, 2000
• Restraining mycobacteria: Role of granulomas in mycobacterial infections
  Immunology & Cell Biology, 2000
• Depressed Interleukin-12 (IL-12), but not IL-18, Production in Response to a 30- or 32-Kilodalton Mycobacterial Antigen in Patients with Active Pulmonary Tuberculosis
  Infection and Immunity, 2000
• Role of Eosinophils in the Pathogenesis of Mycobacterium bovis BCG Infection in Gamma Interferon Receptor-Deficient Mice
  Infection and Immunity, 2000
• Use of Predicted Risk of Mortality to evaluate the efficacy of anticytokine therapy in sepsis
  Critical Care Medicine, 1996
• Resistance to fever induction and impaired acute-phase response in interleukin-1β-deficient mice
  Immunity, 1995
• Tumor necrosis factor-α is required in the protective immune response against mycobacterium tuberculosis in mice
  Immunity, 1995
• Group II phospholipase A₂ mRNA synthesis is stimulated by two distinct mechanisms in rat vascular smooth muscle cells
  FEBS Letters, 1990